The best healthcare stocks from Goldman Sachs' list that are also Quant Strong Buys have attractive valuations and forward ...
Docebo (TSX:DCBO), and Shopify (TSX:SHOP) are three top Canadian AI stocks investors ought to consider right now. The post ...
Read here for latest insights on Tempus AI (TEM) stock's growth in healthcare AI, breakthrough EBITDA, and valuation ...
Down almost 50% from all-time highs, Sylogist is a TSX tech stock that offers significant upside potential in November 2025.
AIRT revenues dip in second-quarter fiscal 2026, but profitability surges as margin gains and asset sales offset weaker ...
Lyft's strong gross bookings, the new Curb partnership and a more appealing valuation place it ahead of the rival in the post ...
Consumer discretionary spending at places like Chipotle is waning as multiple fast-casual chains have pointed to weakness in ...
With an enterprise value of $63.7 billion, CoreWeave still looks reasonably valued at 6 times next year's sales and 9 times ...
Upstart also pulled back on its recent earnings report, giving up 9% on Nov. 6, despite strong results.
Revenue grew 34.2% to ₹1,297 crore from ₹966.6 crore a year ago, while EBITDA increased 37% to ₹278 crore from ₹203.4 crore.
Tesla Inc (NASDAQ: TSLA) shares are trading higher on Monday after Stifel maintained a Buy rating and raised its price target ...
Goldman Sachs expects the global equities to post strong long-term returns despite higher valuations. The firm’s forecast of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results